Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yongping Song

Showing results (101-110 of 252) with videos related to

Pageof 26
Sort By:
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|December 4, 2015
[The first tumor relapse after allogeneic hematopoietic stem cell transplantation in a therapy- related acute myeloid leukemia patient: a case report and literature review]Juan Wang, Jian Zhou, Zhen Li, et al.
Experimental Hematology & Oncology|December 9, 2020
Applications of gut microbiota in patients with hematopoietic stem-cell transplantationJifeng Yu, Hao Sun, Weijie Cao, et al.
Experimental Hematology & Oncology|October 27, 2024
Targeting CD5 chimeric antigen receptor-engineered natural killer cells against T-cell malignanciesYingling Zu, Quan Ren, Jishuai Zhang, et al.
Immunotherapy|August 4, 2016
Cytokine-induced killer cell therapy-associated idiopathic thrombocytopenic purpura: rare but noteworthyXiaomin Fu, Yong Zhang, Quanli Gao, et al.
American Journal of Cancer Research|May 11, 2023
Low-dose decitabine plus bortezomib-dexamethasone therapy is well-tolerated and highly effective on first-relapsed multiple myeloma: a single-center phase 2 trialLijie Liang, Min Zhao, Yuzhang Liu, et al.
Medicine|February 1, 2018
Efficacy and safety of micafungin for the treatment of patients with proven or probable invasive aspergillosis: A non-comparative, multicenter, phase IV, open-label studyYu Ji, Yongping Song, Fang Zhou, et al.
Cancer Cell International|February 24, 2015
Changes of T-lymphocyte subpopulation and differential expression pattern of the T-bet and GATA-3 genes in diffuse large B-cell lymphoma patients after chemotherapyQingsong Yin, Lin Chen, Qianyu Li, et al.
Immunology|May 16, 2022
Advances in the study of CD47-based bispecific antibody in cancer immunotherapyBinglei Zhang, Wei Li, Dandan Fan, et al.
Bone Marrow Transplantation|September 21, 2019
Autologous hematopoietic stem cell infusion for sustained myelosuppression after BCMA-CAR-T therapy in patient with relapsed myelomaQuande Lin, Xiyang Liu, Lu Han, et al.
Cancer Management and Research|February 6, 2020
Effectiveness and Feasibility of Complementary Lung-RADS Version 1.1 in Risk Stratification for pGGN in LDCT Lung Cancer Screening in a Chinese PopulationQingcheng Meng, Pengfei Ren, Pengrui Gao, et al.
Pageof 26

Showing results (101-110 of 252) with videos related to

Sort By:
Pageof 26
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|December 4, 2015
[The first tumor relapse after allogeneic hematopoietic stem cell transplantation in a therapy- related acute myeloid leukemia patient: a case report and literature review]Juan Wang, Jian Zhou, Zhen Li, et al.
Experimental Hematology & Oncology|December 9, 2020
Applications of gut microbiota in patients with hematopoietic stem-cell transplantationJifeng Yu, Hao Sun, Weijie Cao, et al.
Experimental Hematology & Oncology|October 27, 2024
Targeting CD5 chimeric antigen receptor-engineered natural killer cells against T-cell malignanciesYingling Zu, Quan Ren, Jishuai Zhang, et al.
Immunotherapy|August 4, 2016
Cytokine-induced killer cell therapy-associated idiopathic thrombocytopenic purpura: rare but noteworthyXiaomin Fu, Yong Zhang, Quanli Gao, et al.
American Journal of Cancer Research|May 11, 2023
Low-dose decitabine plus bortezomib-dexamethasone therapy is well-tolerated and highly effective on first-relapsed multiple myeloma: a single-center phase 2 trialLijie Liang, Min Zhao, Yuzhang Liu, et al.
Medicine|February 1, 2018
Efficacy and safety of micafungin for the treatment of patients with proven or probable invasive aspergillosis: A non-comparative, multicenter, phase IV, open-label studyYu Ji, Yongping Song, Fang Zhou, et al.
Cancer Cell International|February 24, 2015
Changes of T-lymphocyte subpopulation and differential expression pattern of the T-bet and GATA-3 genes in diffuse large B-cell lymphoma patients after chemotherapyQingsong Yin, Lin Chen, Qianyu Li, et al.
Immunology|May 16, 2022
Advances in the study of CD47-based bispecific antibody in cancer immunotherapyBinglei Zhang, Wei Li, Dandan Fan, et al.
Bone Marrow Transplantation|September 21, 2019
Autologous hematopoietic stem cell infusion for sustained myelosuppression after BCMA-CAR-T therapy in patient with relapsed myelomaQuande Lin, Xiyang Liu, Lu Han, et al.
Cancer Management and Research|February 6, 2020
Effectiveness and Feasibility of Complementary Lung-RADS Version 1.1 in Risk Stratification for pGGN in LDCT Lung Cancer Screening in a Chinese PopulationQingcheng Meng, Pengfei Ren, Pengrui Gao, et al.
Pageof 26